Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-20

Clinical Trial Update: Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

View source ↗

Summary

An observational trial evaluating tolerability and efficacy of Resiquimod Gel in patients with actinic keratosis was terminated, with results posted in January …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resiquimod Gel (resiquimod)

Snippet

Sponsor: Spirig Pharma Ltd. | Conditions: Actinic Keratosis | Status: TERMINATED | Results posted: 2016-01-20